Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004576:Electromyography; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D018482:Muscle, Skeletal / Q000503:physiopathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D020127:Recovery of Function; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000503:physiopathology / Q000534:rehabilitation*; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin